{"id":451858,"date":"2021-03-05T11:01:01","date_gmt":"2021-03-05T16:01:01","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451858"},"modified":"2021-03-05T11:01:01","modified_gmt":"2021-03-05T16:01:01","slug":"nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/","title":{"rendered":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Miami, March  05, 2021  (GLOBE NEWSWIRE) &#8212; Nicklaus Children\u2019s Hospital has announced availability of the Pfizer-BioNTech vaccine for Florida\u2019s children and young adults ages 16 to 21 who are currently under the care of physicians or specialists for medical conditions identified by the Centers for Disease Control (CDC) as posing an increased risk for severe illness associated with COVID-19.<\/p>\n<p>The hospital has already vaccinated 500 eligible patients through outreach to other area hospitals and health systems, pediatricians and pediatric subspecialists in Florida that resulted in hundreds of referrals for vaccine appointments. Nicklaus Children\u2019s recently received an additional allotment of the Pfizer-BioNTech vaccine, enabling the hospital to extend its offering on a broader level. Appointment requests can be submitted through the web link below, effective Monday, March 8, 2021.<\/p>\n<p>\u201cNicklaus Children\u2019s is committed to our mission of prioritizing the children and young adults of our community and beyond. While most children are only mildly affected by COVID-19, those with complex conditions may be at risk of severe illness if they contract the virus. We are honored to be able to offer the vaccine to support the care of vulnerable children in Florida,\u201d said Matthew A. Love, President and CEO of Nicklaus Children\u2019s Health System, parent organization of the hospital.<\/p>\n<p>Nicklaus Children\u2019s is able to offer the vaccine to children and young adults ages 16 to 21 who provide written correspondence from a physician confirming that they are being treated for one or more of the conditions identified by the CDC as increasing the risk associated with COVID-19. These include asthma (moderate to severe), cancer, cerebrovascular disease, chronic kidney disease, cystic fibrosis, diabetes (type 1 or 2), Down syndrome, heart conditions, hypertension, immunocompromised conditions, liver disease, neurologic conditions, obesity, pulmonary fibrosis, sickle cell disease or thalassemia. Individuals older than 21 and under the medical care of a pediatrician or pediatric specialist are also being evaluated on a case-by-case basis.<\/p>\n<p>Interested families should visit <b>Nicklauschildrens.org\/Covid19Vaccine<\/b> for more information. Vaccine appointments can be requested on this page effective Monday, March 8, 2021.\u00a0<\/p>\n<p>\n        <b>Photos for media use: <\/b>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3tpbI1FIqh_IbfOenyMONkT3LjW8lDuc88JDgx2nUXzpEXNAGMQ94Rs61Dnp9ADXy34pSA-zk0OhOhXjPAqKHP0BgQ2nLLxalrXlffzg3huS3zZCi_ZW8mKm71jBCaUEJr805rCPGBX_KZOSglDG4CMKaug3zieIfCf09noydsD2RV83UW32INfUl1YrtIRB\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/upload.nicklaushealth.org\/link\/79JIUlSrKMDLeRXhXHSm99<\/a>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3tpbI1FIqh_IbfOenyMONkT3LjW8lDuc88JDgx2nUXzpEXNAGMQ94Rs61Dnp9ADXhxAvWq-_OY6yVPrk3Cf1UdKJ1uAAhSdDtY-D2xVYAXGUqNULU4hDMmd4xyeVkdncf-WbNac4s7NsmK8rRlPljWYyI1zsTjt0y7JHVsVbkYXpMYvJgiRzOsumRK39_tjz\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/upload.nicklaushealth.org\/link\/2HNdtd7OPdm7ibQqFAu8qx<\/a>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3tpbI1FIqh_IbfOenyMONkT3LjW8lDuc88JDgx2nUXzpEXNAGMQ94Rs61Dnp9ADXkBeXtBvXBsEclvPJ3rm1ITeF_jiscwal16W6wH_BWpHbVZLoc1letZe_DFB5xkf7Hgp7iiHY35aHRNJfxcoQpT5-Dzt7tTs38qGP0qfVFuklGq7mt1TJLEayINzO5zg3\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/upload.nicklaushealth.org\/link\/LHCqVxogynQ5Hzo8AAHRHA<\/a>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3tpbI1FIqh_IbfOenyMONkT3LjW8lDuc88JDgx2nUXzpEXNAGMQ94Rs61Dnp9ADX-L_M3wSm3R0-fmTERSf1zrjlrF7BBEmGbMZ3DDIMw7sTJ0WklvWhu8bFMcncRoVAy9fdYPok03aiR0bf9Mx1DXxgodjAXaq7jeI-Q2Z05S9ihjlZCVGDkYMW_yqVWTI_RyimEXClBsPXVuax2bcxiw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/upload.nicklaushealth.org\/link\/tp1A9iYlmD616UOg8fljL7<\/a>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3tpbI1FIqh_IbfOenyMONkT3LjW8lDuc88JDgx2nUXzpEXNAGMQ94Rs61Dnp9ADXP2mVDFtPPHC8cM3OpHOvcKwGxS2bRfXDe1Bh7LzScjEyH71G0RzGAsMGPXWc5qZeX9Ro8kPVvBMEs-RC7YSbucrBDjN1GZAI66PD-jBnooRuGfibrmatkde3KiyqNmv32kHmMTkJqnEhjyOtiuIi-A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/upload.nicklaushealth.org\/link\/OObHqcO7IvMkE4okAMzQQx<\/a>\n      <\/p>\n<p>\u00a0<\/p>\n<p>\n        <b>About Nicklaus Children\u2019s Hospital\u00a0<\/b><br \/>\n        <br \/> Founded in 1950 by Variety Clubs International, Nicklaus Children\u2019s Hospital is South Florida\u2019s only licensed specialty hospital exclusively for children, with nearly 800 attending physicians, including more than 475 pediatric subspecialists. The 309-bed hospital, known as Miami Children\u2019s Hospital from 1983 through 2014, is renowned for excellence in all aspects of pediatric medicine with many specialty programs routinely ranked among the best in the nation by <i>U.S. News &amp; World Report<\/i> since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession\u2019s most prestigious institutional honor. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x-agDeQfSWGlWLoGNs2VH5_oc_RuF5zuU_D18J24hUMrdbnp44049NT-ivv3yFfb9uSkPMAvYPRFYKzdO5GnhOFAATivu1xElPaArRyqPVQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.nicklauschildrens.org<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d125afcf-8993-40ba-b77c-ad93978abab9\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Gabriela Rodriguez\r\nNicklaus Children&amp;apos;s Hospital\r\n305-331-7026\r\ngabriela.rodriguez@nicklaushealth.org\r\n\r\nRachel Bixby\r\nNicklaus Children&amp;apos;s Hospital\r\n305-898-9165\r\nrachel.bixby@nicklaushealth.org\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Miami, March 05, 2021 (GLOBE NEWSWIRE) &#8212; Nicklaus Children\u2019s Hospital has announced availability of the Pfizer-BioNTech vaccine for Florida\u2019s children and young adults ages 16 to 21 who are currently under the care of physicians or specialists for medical conditions identified by the Centers for Disease Control (CDC) as posing an increased risk for severe illness associated with COVID-19. The hospital has already vaccinated 500 eligible patients through outreach to other area hospitals and health systems, pediatricians and pediatric subspecialists in Florida that resulted in hundreds of referrals for vaccine appointments. Nicklaus Children\u2019s recently received an additional allotment of the Pfizer-BioNTech vaccine, enabling the hospital to extend its offering on a broader level. Appointment requests can be submitted through the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451858","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Miami, March 05, 2021 (GLOBE NEWSWIRE) &#8212; Nicklaus Children\u2019s Hospital has announced availability of the Pfizer-BioNTech vaccine for Florida\u2019s children and young adults ages 16 to 21 who are currently under the care of physicians or specialists for medical conditions identified by the Centers for Disease Control (CDC) as posing an increased risk for severe illness associated with COVID-19. The hospital has already vaccinated 500 eligible patients through outreach to other area hospitals and health systems, pediatricians and pediatric subspecialists in Florida that resulted in hundreds of referrals for vaccine appointments. Nicklaus Children\u2019s recently received an additional allotment of the Pfizer-BioNTech vaccine, enabling the hospital to extend its offering on a broader level. Appointment requests can be submitted through the &hellip; Continue reading &quot;NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T16:01:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS\",\"datePublished\":\"2021-03-05T16:01:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/\"},\"wordCount\":510,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/\",\"name\":\"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\",\"datePublished\":\"2021-03-05T16:01:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/","og_locale":"en_US","og_type":"article","og_title":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk","og_description":"Miami, March 05, 2021 (GLOBE NEWSWIRE) &#8212; Nicklaus Children\u2019s Hospital has announced availability of the Pfizer-BioNTech vaccine for Florida\u2019s children and young adults ages 16 to 21 who are currently under the care of physicians or specialists for medical conditions identified by the Centers for Disease Control (CDC) as posing an increased risk for severe illness associated with COVID-19. The hospital has already vaccinated 500 eligible patients through outreach to other area hospitals and health systems, pediatricians and pediatric subspecialists in Florida that resulted in hundreds of referrals for vaccine appointments. Nicklaus Children\u2019s recently received an additional allotment of the Pfizer-BioNTech vaccine, enabling the hospital to extend its offering on a broader level. Appointment requests can be submitted through the &hellip; Continue reading \"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-05T16:01:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS","datePublished":"2021-03-05T16:01:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/"},"wordCount":510,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/","name":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=","datePublished":"2021-03-05T16:01:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTMwNiM0MDUwNzU0IzIyMDc0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nicklaus-childrens-offers-covid-19-vaccine-to-at-risk-children-and-young-adults\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NICKLAUS CHILDREN\u2019S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451858"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}